99 related articles for article (PubMed ID: 8363777)
1. Cell-mediated immunity in HIV infection.
Clerici M
AIDS; 1993; 7 Suppl 1():S135-40. PubMed ID: 8363777
[No Abstract] [Full Text] [Related]
2. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope.
Emini EA; Koff WC
Science; 2004 Jun; 304(5679):1913-4. PubMed ID: 15218131
[No Abstract] [Full Text] [Related]
3. HIV/AIDS vaccines: 2007.
Robinson HL
Clin Pharmacol Ther; 2007 Dec; 82(6):686-93. PubMed ID: 17971817
[TBL] [Abstract][Full Text] [Related]
4. Public health. A sound rationale needed for phase III HIV-1 vaccine trials.
Burton DR; Desrosiers RC; Doms RW; Feinberg MB; Gallo RC; Hahn B; Hoxie JA; Hunter E; Korber B; Landay A; Lederman MM; Lieberman J; McCune JM; Moore JP; Nathanson N; Picker L; Richman D; Rinaldo C; Stevenson M; Watkins DI; Wolinsky SM; Zack JA
Science; 2004 Jan; 303(5656):316. PubMed ID: 14726576
[No Abstract] [Full Text] [Related]
5. A brief history of HIV vaccine research: stepping back to the drawing board?
Miedema F
AIDS; 2008 Sep; 22(14):1699-703. PubMed ID: 18753857
[TBL] [Abstract][Full Text] [Related]
6. Mapping the future of HIV vaccines.
Nabel GJ
Nat Rev Microbiol; 2007 Jul; 5(7):482-4. PubMed ID: 17571457
[No Abstract] [Full Text] [Related]
7. Cellular immune responses to HIV.
McMichael AJ; Rowland-Jones SL
Nature; 2001 Apr; 410(6831):980-7. PubMed ID: 11309628
[TBL] [Abstract][Full Text] [Related]
8. Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development.
Betts MR; Gray CM; Cox JH; Ferrari G
Expert Rev Vaccines; 2006 Aug; 5(4):505-16. PubMed ID: 16989631
[TBL] [Abstract][Full Text] [Related]
9. Heterologous prime-boost vaccination strategies for HIV-1: augmenting cellular immune responses.
Newman MJ
Curr Opin Investig Drugs; 2002 Mar; 3(3):374-8. PubMed ID: 12054082
[TBL] [Abstract][Full Text] [Related]
10. Protection from HIV infection or AIDS?
Miedema F; Meyaard L; Klein MR
Science; 1993 Nov; 262(5136):1074-6. PubMed ID: 8235627
[No Abstract] [Full Text] [Related]
11. HIV type 1-specific helper T cells: a critical host defense.
Rosenberg ES; Walker BD
AIDS Res Hum Retroviruses; 1998 Jun; 14 Suppl 2():S143-7. PubMed ID: 9672231
[No Abstract] [Full Text] [Related]
12. Progress and obstacles in the development of an AIDS vaccine.
Letvin NL
Nat Rev Immunol; 2006 Dec; 6(12):930-9. PubMed ID: 17124514
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic immunization with an inactivated HIV-1 Immunogen plus antiretrovirals versus antiretroviral therapy alone in asymptomatic HIV-infected subjects.
Fernandez-Cruz E; Moreno S; Navarro J; Clotet B; Bouza E; Carbone J; Peña JM; Pérez Molina J; Podzamczer D; Rubio R; Ocaña I; Pulido F; Viciana P; Maradona JA; Blazquez R; Barros C; Quereda C; Rodriguez-Sainz C; Gil J; Abad ML; Díaz L; Cantó C; Muñoz MA; Ferrer E; Jou A; Sirera G; Díaz M; Lopez F; Gatell JM; Gonzalez-Lahoz J;
Vaccine; 2004 Aug; 22(23-24):2966-73. PubMed ID: 15297045
[TBL] [Abstract][Full Text] [Related]
14. New strategies to combat HIV: augmenting antiviral immunity.
Smith KA; Boyle BA
AIDS Read; 2003 Aug; 13(8):365-9, 382. PubMed ID: 14524321
[No Abstract] [Full Text] [Related]
15. Support for the RV144 HIV vaccine trial.
Belshe R; Franchini G; Girard MP; Gotch F; Kaleebu P; Marthas ML; McChesney MB; McCullough R; Mhalu F; Salmon-Ceron D; Sekaly RP; van Rompay K; Verrier B; Wahren B; Weissenbacher M
Science; 2004 Jul; 305(5681):177-80; author reply 177-80. PubMed ID: 15247455
[No Abstract] [Full Text] [Related]
16. Human versus HIV: round 2 defeat in AIDS vaccine development.
Lu S
Expert Rev Vaccines; 2008 Mar; 7(2):151-3. PubMed ID: 18324884
[No Abstract] [Full Text] [Related]
17. Vaccines and immunology: elucidating immunity to HIV-1 and current prospects for AIDS vaccine development.
Heeney JL; Hahn BH
AIDS; 2000; 14 Suppl 3():S125-7. PubMed ID: 11086855
[No Abstract] [Full Text] [Related]
18. Phenotypic analysis of human immunodeficiency virus (HIV) type 1 cell-mediated immune responses after treatment with an HIV-1 immunogen.
Moss RB; Wallace MR; Giermakowska WK; Webb E; Savary J; Chamberlin-Brandt C; Theofan G; Musil R; Richieri SP; Jensen FC; Carlo DJ
J Infect Dis; 1999 Sep; 180(3):641-8. PubMed ID: 10438350
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic dendritic-cell vaccine for chronic HIV-1 infection.
Lu W; Arraes LC; Ferreira WT; Andrieu JM
Nat Med; 2004 Dec; 10(12):1359-65. PubMed ID: 15568033
[TBL] [Abstract][Full Text] [Related]
20. Can immune responses to human immunodeficiency virus be preserved, enhanced, or restored?
Walker BD
AIDS Clin Rev; 2000-2001; ():101-14. PubMed ID: 10999218
[No Abstract] [Full Text] [Related]
[Next] [New Search]